XML 44 R27.htm IDEA: XBRL DOCUMENT v3.22.0.1
Schedule II - Condensed Financial Information Of The Registrant
12 Months Ended
Dec. 31, 2021
Schedule II - Condensed Financial Information Of The Registrant [Abstract]  
Schedule II - Condensed Financial Information Of The Registrant

SCHEDULE II — CONDENSED FINANCIAL INFORMATION OF THE REGISTRANT

CONDENSED BALANCE SHEETS

 

December 31,

 

(Dollars and share amounts in thousands, except par value per share)

2021

 

2020

 

 

 

 

 

 

 

 

ASSETS:

 

 

 

 

 

 

Fixed maturities - available for sale

$

-

 

$

3

 

(amortized cost: 2021, $0; 2020, $3)

 

 

 

 

 

 

Other invested assets (cost: 2021, $211,612; 2020, $282,762)

 

211,612

 

 

282,762

 

Cash

 

3,253

 

 

884

 

Investment in subsidiaries, at equity in the underlying net assets

 

10,353,351

 

 

9,660,713

 

Accrued investment income

 

-

 

 

-

 

Receivable from subsidiaries

 

9,936

 

 

18,424

 

Other assets

 

50,061

 

 

64,692

 

TOTAL ASSETS

$

10,628,213

 

$

10,027,478

 

 

 

 

 

 

 

 

LIABILITIES:

 

 

 

 

 

 

Long term notes payable, affiliated

$

500,000

 

$

300,000

 

Due to subsidiaries

 

1,622

 

 

1,933

 

Other liabilities

 

(12,589)

 

 

(631)

 

Total liabilities

 

489,033

 

 

301,302

 

 

 

 

 

 

 

 

SHAREHOLDERS' EQUITY:

 

 

 

 

 

 

Preferred shares, par value: $0.01; 50,000 shares authorized;

 

 

 

 

 

 

no shares issued and outstanding

 

-

 

 

-

 

Common shares, par value: $0.01; 200,000 shares authorized

 

 

 

 

 

 

(2021) 69,790and (2020) 69,620 issued outstanding before treasury shares

 

698

 

 

696

 

Additional paid-in capital

 

2,274,431

 

 

2,245,301

 

Accumulated other comprehensive income (loss), net of deferred income

 

 

 

 

 

 

tax expense (benefit) of $26,781 at 2021 and $80,451 at 2020

 

11,523

 

 

534,899

 

Treasury shares, at cost; 30,524 shares (2021) and 29,636 shares (2020)

 

(3,847,308)

 

 

(3,622,172)

 

Retained earnings

 

11,699,836

 

 

10,567,452

 

Total shareholders' equity

 

10,139,180

 

 

9,726,176

 

TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY

$

10,628,213

 

$

10,027,478

 

 

 

 

 

 

 

 

See notes to consolidated financial statements.

 

 

 

 

 

 

 

 

SCHEDULE II — CONDENSED FINANCIAL INFORMATION OF THE REGISTRANT

CONDENSED STATEMENTS OF OPERATIONS

 

Years Ended December 31,

 

 

2021

 

 

2020

 

 

2019

(Dollars in thousands)

 

 

 

 

 

 

 

 

REVENUES:

 

 

 

 

 

 

 

 

Net investment income

$

228

 

$

1,121

 

$

3,484

Net realized capital gains (losses)

 

-

 

 

28

 

 

(66)

Other income (expense)

 

(185)

 

 

5,833

 

 

458

Net income (loss) of subsidiaries

 

1,416,451

 

 

535,866

 

 

1,026,233

Total revenues

 

1,416,494

 

 

542,848

 

 

1,030,109

 

 

 

 

 

 

 

 

 

EXPENSES:

 

 

 

 

 

 

 

 

Interest expense - affiliated

 

5,952

 

 

5,155

 

 

2,087

Other expenses

 

31,459

 

 

23,542

 

 

18,561

Total expenses

 

37,411

 

 

28,697

 

 

20,648

 

 

 

 

 

 

 

 

 

INCOME (LOSS) BEFORE TAXES

 

1,379,083

 

 

514,151

 

 

1,009,461

 

 

 

 

 

 

 

 

 

NET INCOME (LOSS)

$

1,379,083

 

$

514,151

 

$

1,009,461

 

 

 

 

 

 

 

 

 

Other comprehensive income (loss), net of tax:

 

 

 

 

 

 

 

 

Unrealized appreciation (depreciation) ("URA(D)") on securities arising during the period

 

(488,378)

 

 

423,210

 

 

496,430

Reclassification adjustment for realized losses (gains) included in net income (loss)

 

3,616

 

 

(3,476)

 

 

(12,613)

Total URA(D) on securities arising during the period

 

(484,762)

 

 

419,734

 

 

483,817

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustments

 

(62,091)

 

 

86,327

 

 

14,030

 

 

 

 

 

 

 

 

 

Benefit plan actuarial net gain (loss) for the period

 

6,250

 

 

(5,615)

 

 

(12,591)

Reclassification adjustment for amortization of net (gain) loss included in net income (loss)

 

17,227

 

 

6,300

 

 

5,453

Total benefit plan net gain (loss) for the period

 

23,478

 

 

685

 

 

(7,138)

Total other comprehensive income (loss), net of tax

 

(523,375)

 

 

506,746

 

 

490,709

 

 

 

 

 

 

 

 

 

COMPREHENSIVE INCOME (LOSS)

$

855,708

 

$

1,020,897

 

$

1,500,170

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

See notes to consolidated financial statements.

 

 

 

 

 

 

 

 

SCHEDULE II — CONDENSED FINANCIAL INFORMATION OF THE REGISTRANT

CONDENSED STATEMENTS OF CASH FLOWS

 

Years Ended December 31,

 

 

(Dollars in thousands)

 

2021

 

 

2020

 

 

2019

 

 

CASH FLOWS FROM OPERATING ACTIVITIES:

 

 

 

 

 

 

 

 

 

 

Net income (loss)

$

1,379,083

 

$

514,151

 

$

1,009,461

 

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

 

 

 

 

Equity in retained (earnings) deficit of subsidiaries

 

(1,416,451)

 

 

(535,866)

 

 

(1,026,233)

 

 

Dividends received from subsidiaries

 

320,000

 

 

650,000

 

 

600,000

 

 

Change in other assets and liabilities, net

 

2,676

 

 

(21,145)

 

 

564

 

 

Increase (decrease) in due to/from affiliates

 

8,176

 

 

(8,621)

 

 

(2,209)

 

 

Amortization of bond premium (accrual of bond discount)

 

-

 

 

(14)

 

 

(9)

 

 

Realized capital losses (gains)

 

-

 

 

(28)

 

 

66

 

 

Non-cash compensation expense

 

2,481

 

 

2,588

 

 

2,796

 

 

Net cash provided by (used in) operating activities

 

295,965

 

 

601,065

 

 

584,436

 

 

 

 

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES:

 

 

 

 

 

 

 

 

 

 

Additional investment in subsidiaries

 

(119,598)

 

 

(138,320)

 

 

(478,125)

 

 

Proceeds from fixed maturities matured/called - available for sale, at market value

 

3

 

 

1,356

 

 

63

 

 

Proceeds from fixed maturities sold - available for sale, at market value

 

-

 

 

200,264

 

 

74,841

 

 

Distribution from other invested assets

 

606,648

 

 

559,767

 

 

644,918

 

 

Cost of fixed maturities acquired - available for sale, at market value

 

-

 

 

-

 

 

(200,267)

 

 

Cost of other invested assets acquired

 

(535,499)

 

 

(800,828)

 

 

(686,528)

 

 

Net change in short-term investments

 

-

 

 

-

 

 

-

 

 

Net cash provided by (used in) investing activities

 

(48,446)

 

 

(177,761)

 

 

(645,098)

 

 

 

 

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES:

 

 

 

 

 

 

 

 

 

 

Common shares issued during the period, net

 

26,685

 

 

23,185

 

 

22,861

 

 

Purchase of treasury shares

 

(225,136)

 

 

(200,020)

 

 

(24,604)

 

 

Dividends paid to shareholders

 

(246,699)

 

 

(249,056)

 

 

(234,322)

 

 

Proceeds from issuance (cost of repayment) of long term notes payable - affiliated

 

200,000

 

 

-

 

 

300,000

 

 

Net cash provided by (used in) financing activities

 

(245,150)

 

 

(425,891)

 

 

63,935

 

 

 

 

 

 

 

 

 

 

 

 

 

EFFECT OF EXCHANGE RATE CHANGES ON CASH

 

-

 

 

-

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

Net increase (decrease) in cash

 

2,369

 

 

(2,587)

 

 

3,273

 

 

Cash, beginning of period

 

884

 

 

3,471

 

 

198

 

 

Cash, end of period

$

3,253

 

$

884

 

$

3,471

 

 

 

 

 

 

 

 

 

 

 

 

 

See notes to consolidated financial statements.

 

 

 

 

 

 

 

 

 

 

SCHEDULE II – CONDENSED FINANCIAL INFORMATION OF THE REGISTRANT

NOTES to conDENSED financial information

 

 

 

 

1.) The accompanying condensed financial information should be read in conjunction with the consolidated financial statements and related Notes of Everest Re Group, Ltd. and its Subsidiaries.

 

2.) Everest Re Group, Ltd. entered into a $300 million long term note agreement with Everest Reinsurance Company, an affiliated company, as of December 17, 2019. The note will pay interest annually at a rate of 1.69 % and is scheduled to mature in December 2028. At December 31, 2021 and 2020, this transaction was presented as a Long Term Note Payable – Affiliated in the Condensed Balance sheets of Everest Re Group, Ltd.

 

3.) Everest Re Group, Ltd. entered into a $200 million long term note agreement with Everest Reinsurance Company, an affiliated company, as of August 5, 2021. The note will pay interest annually at a rate of 1.00 % and is scheduled to mature in August 2030. At December 31, 2021, this transaction was presented as a Long Term Note Payable – Affiliated in the Condensed Balance sheets of Everest Re Group, Ltd.

 

4.) Everest Re Group, Ltd. has invested funds in the segregated accounts of Mt. Logan Re, Ltd. (“Mt. Logan Re”), an affiliated entity. On the Condensed Balance Sheets, investments in Mt. Logan Re valued at $66.3 million and $67.6 million as of December 31, 2021 and 2020, respectively, have been recorded within Other Assets. On the Condensed Statements of Operations, income (expense) of $1.3 million, $6.3 million and $0.8 million for the years ended December 31, 2021, 2020 and 2019, respectively, have been recorded in other income (expense).